Skip to main content
Premium Trial:

Request an Annual Quote

USPTO Publishes Five RNAi-Related Patent Applications: Feb 22, 2007

Premium
Title: Functional and Hyperfunctional siRNA
 
Number: 20070039072
 
Filed: March 29, 2005
 
Lead Inventor: Anastasia Khvorova, Dharmacon (Thermo Fisher Scientific)
 
According to the patent application’s abstract, “efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.”
 

 
Title: Cell-Signaling Genes and Related Methods
 
Number: 20070039071
 
Filed: June 16, 2006
 
Lead Inventor: Shujun Chang, ArborGen
 
The patent application, its abstract states, covers “novel plant cell signaling genes and gene products. … These gene, polypeptide, and oligonucleotide sequences are useful in regulating plant phenotype. Moreover, these genes and gene products are useful for expression profiling of plant cell signaling genes. The invention specifically provides polynucleotide and polypeptide sequences isolated from Eucalyptus and Pinus species,” the abstract adds.
 

 
Title: Compositions and Methods for siRNA Inhibition of Angiogenesis
 
Numbers: 20070037762, 20070037761, and 20070037760
 
Filed: June 8, 2006
 
Lead Inventor: Michael Tolentino, University of Pennsylvania (Acuity Pharmaceuticals)
 
“RNA interference using small interfering RNAs, which are specific for the vascular endothelial growth factor gene and the VEGF receptor genes Flt-1 and Flk-1/KDR, [inhibits] expression of these genes,” the patent application’s abstract states. “Diseases which involve antiogenesis stimulated by overexpression of VEGF, such as diabetic retinopathy, age-related macular degeneration, and many types of cancer, can be treated by administering the small interfering RNAs.”

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.